1989
DOI: 10.1161/01.res.65.1.1
|View full text |Cite
|
Sign up to set email alerts
|

Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

15
381
2
11

Year Published

1993
1993
2013
2013

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 898 publications
(409 citation statements)
references
References 168 publications
15
381
2
11
Order By: Relevance
“…Since human primary hypertension is associated with increased peripheral vascular resistance (28), there are theoretical reasons why reduced NO production or bioavailability could lead to vasoconstriction, and hence, increased peripheral vascular resistance, resulting in hypertension. Incubation of blood vessels with cadmium was reported to inhibit endothelium-dependent vasorelaxation (21), which is mainly mediated by NO from the vascular endothelium (29). However, it has not been determined whether vasorelaxation is altered in cadmium-accumulated blood vessels.…”
Section: Discussionmentioning
confidence: 99%
“…Since human primary hypertension is associated with increased peripheral vascular resistance (28), there are theoretical reasons why reduced NO production or bioavailability could lead to vasoconstriction, and hence, increased peripheral vascular resistance, resulting in hypertension. Incubation of blood vessels with cadmium was reported to inhibit endothelium-dependent vasorelaxation (21), which is mainly mediated by NO from the vascular endothelium (29). However, it has not been determined whether vasorelaxation is altered in cadmium-accumulated blood vessels.…”
Section: Discussionmentioning
confidence: 99%
“…Nitric oxide (NO) or a related substance has been shown to be an endothelium-derived relaxing factor (Ignarro, 1989;Moncada et aI., 1991). NO, which is synthesized from the terminal guanidino nitrogen atoms of the basic amino acid L-arginine (Palmer et ai., 1988) by NO synthases (Bredt and Snyder, 1990;Stuehr et al, 1991), induces vasodilation via activation of soluble guanylate cyclase (Ignarro, 1989;Moncada et aI., 1991).…”
mentioning
confidence: 99%
“…NO, which is synthesized from the terminal guanidino nitrogen atoms of the basic amino acid L-arginine (Palmer et ai., 1988) by NO synthases (Bredt and Snyder, 1990;Stuehr et al, 1991), induces vasodilation via activation of soluble guanylate cyclase (Ignarro, 1989;Moncada et aI., 1991). Accordingly, an over production of NO resulting from induction of an inducible NO synthase in endothelial and smooth muscle cells by endotoxin, and therefore a decrease in vascular reactivity, have been implicated in sep tic shock following bacterial infection (Knowles et aI., 1990;Radomski et aI., 1990;Salvemini et aI., 1990Salvemini et aI., , 1992.…”
mentioning
confidence: 99%
“…Nitric oxide has a very short half-life (2 to 5 s), making it easy to administer into the lungs. 6 Early experiments in animals showed that iNO produced acute and sustained vasodilatation when given via inhalation. 7 These initial results led to pilot trials in babies showing that, when iNO was administered in severe pulmonary hypertension, an improvement in oxygenation was seen.…”
Section: Introductionmentioning
confidence: 99%